Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Antoñanzas

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Pharmacoeconomics|April 23, 2021
Hispa-NICE: A Pipe Dream or a Realistic and Necessary Initiative?Fernando Antoñanzas
Gaceta Sanitaria|October 17, 2006
[Comment. On studies of the costs of healthcare processes]Fernando Antoñanzas
Pharmacoeconomics|August 27, 2004
Transferability of economic evaluation resultsFernando Antoñanzas
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 9, 2003
Challenges to achieving value in drug spending in a decentralized country: the Spanish caseFernando Antoñanzas
Revista Espanola De Salud Publica|July 30, 2013
[Non safety costs in the Spanish health care system]Fernando Antoñanzas Villar
Pharmacoeconomics|October 13, 2010
New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunitionFernando Antoñanzas, Pedro Gómez
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 12, 2007
Tobacco policies in the European Union: a need for state and continental harmonisation?Fernando Antoñanzas, Roberto Rodríguez
European Journal of Public Health|January 1, 2003
Information disclosure and smoking risk perceptions. Potential short-term impact on Spanish students of the new European Union directive on tobacco productsFabiola Portillo, Fernando Antoñanzas
Antibiotics (Basel, Switzerland)|July 26, 2020
Policies to Reduce Antibiotic Consumption: The Impact in the Basque CountryPaula Rojas, Fernando Antoñanzas
Pharmacoeconomics|August 12, 2009
Economic evaluations in the EURONHEED: a comparative analysisFlorencia Hutter, Fernando Antoñanzas
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Pharmacoeconomics|April 23, 2021
Hispa-NICE: A Pipe Dream or a Realistic and Necessary Initiative?Fernando Antoñanzas
Gaceta Sanitaria|October 17, 2006
[Comment. On studies of the costs of healthcare processes]Fernando Antoñanzas
Pharmacoeconomics|August 27, 2004
Transferability of economic evaluation resultsFernando Antoñanzas
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 9, 2003
Challenges to achieving value in drug spending in a decentralized country: the Spanish caseFernando Antoñanzas
Revista Espanola De Salud Publica|July 30, 2013
[Non safety costs in the Spanish health care system]Fernando Antoñanzas Villar
Pharmacoeconomics|October 13, 2010
New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunitionFernando Antoñanzas, Pedro Gómez
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 12, 2007
Tobacco policies in the European Union: a need for state and continental harmonisation?Fernando Antoñanzas, Roberto Rodríguez
European Journal of Public Health|January 1, 2003
Information disclosure and smoking risk perceptions. Potential short-term impact on Spanish students of the new European Union directive on tobacco productsFabiola Portillo, Fernando Antoñanzas
Antibiotics (Basel, Switzerland)|July 26, 2020
Policies to Reduce Antibiotic Consumption: The Impact in the Basque CountryPaula Rojas, Fernando Antoñanzas
Pharmacoeconomics|August 12, 2009
Economic evaluations in the EURONHEED: a comparative analysisFlorencia Hutter, Fernando Antoñanzas
Pageof 8